Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02269371 · ClinicalTrials.gov registry record · NA
Auricular Acupuncture in the Treatment of Obesity
A NA study, sponsored by Mike O'Callaghan Military Hospital.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT02269371: Completed NA study, sponsored by Mike O'Callaghan Military Hospital.
NCT02269371 is a NA study that has completed, run by Mike O'Callaghan Military Hospital. The registered enrollment target is 82 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02269371, a NA study, has completed, sponsored by Mike O'Callaghan Military Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
Male and female DoD beneficiaries ages 18 years or older, who are referred for a standard of care weight loss intervention for treatment of obesity will be recruited. Subjects will be randomized into one of two groups receiving either a standard of care weight loss intervention plus auricular acupuncture at Shen Men, Point Zero, and Appetite Control Point/Hunger Point or receiving a standard of care weight loss intervention plus sham auricular acupuncture. Subjects will receive treatment in accordance with their randomization group for 12 weeks then have one additional follow up visit at week 24. The following measures will be obtained: height, weight, waist circumference, and Body Mass Index will be calculated.
Primary Outcome
As assessed by weight in pounds. Weight change between baseline and week 24. Positive number equals pounds lost.
Interventions
- OTHER Sham Acupuncture
- OTHER Auricular Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02269371 record still lists
NCT02269371 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham Acupuncture is the first listed.
NCT02269371 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02269371 about?
NCT02269371 is a clinical study titled "Auricular Acupuncture in the Treatment of Obesity". Male and female DoD beneficiaries ages 18 years or older, who are referred for a standard of care weight loss intervention for treatment of obesity will be recruited. Subjects will be randomized into one of two groups receiving either a standard of care weight loss intervention plus auricular acupun...
What is the current status of trial NCT02269371?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2015-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02269371?
The interventions under investigation include: Sham Acupuncture (OTHER), Auricular Acupuncture (OTHER).
Who is sponsoring clinical trial NCT02269371?
This trial is sponsored by Mike O'Callaghan Military Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02269371's enrollment target sits among peer trials
82 990th of 2000 higher than 1,009 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia